• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查:评估粪便免疫化学检测阴性受试者中[具体指标未给出]、[具体指标未给出]、[具体指标未给出]和[具体指标未给出]作为血液标志物的情况。

Colorectal cancer screening: Assessment of , , and as blood markers in faecal immunochemical test negative subjects.

作者信息

Ferlizza Enea, Solmi Rossella, Miglio Rossella, Nardi Elena, Mattei Gabriella, Sgarzi Michela, Lauriola Mattia

机构信息

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Belmeloro 8, 40126 Bologna, Italy.

Department of Statistical Sciences, University of Bologna, Via Belle Arti 42, 40100 Bologna, Italy.

出版信息

J Adv Res. 2020 Mar 3;24:99-107. doi: 10.1016/j.jare.2020.03.001. eCollection 2020 Jul.

DOI:10.1016/j.jare.2020.03.001
PMID:32257432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7113625/
Abstract

Prevention is essential to reduce Colorectal Cancer (CRC) mortality. We previously reported a panel of four genes: able to discriminate patients with CRC. Here, we assessed the CELTiC panel by quantitative polymerase chain reaction, in the blood of 174 healthy subjects, who resulted negative to the faecal immunochemical test (FITN). Using non-parametric statistic and multinomial logistic models, the FITN were compared to previously analysed subjects: 36 false positive FIT (NFIT), who were negative at colonoscopy, 36 patients with low risk lesions (LR) and 92 patients with high risk lesions or CRC (HR/CRC). FITN showed a significantly lower expression of the four genes when compared to HR/CRC. Moreover, FITN showed a significantly lower expression of and compared to NFIT and LR patients. The multinomial logistic model confirmed that alone specifically discriminated FITN from NFIT, LR and HR/CRC, while was able to differentiate FITN from false positive FIT. Finally, ROC curves analysis of the comparisons between FITN and HR/CRC, LR or NFIT reported AUC greater than 0.87, with a sensitivity and specificity of 83% and 76%, respectively. The CELTiC panel was confirmed a useful tool to identify CRC patients and to discriminate false FIT positive subjects.

摘要

预防对于降低结直肠癌(CRC)死亡率至关重要。我们之前报告了一组四个基因,能够区分CRC患者。在此,我们通过定量聚合酶链反应在174名粪便免疫化学检测(FITN)结果为阴性的健康受试者血液中评估了CELTiC检测组。使用非参数统计和多项逻辑模型,将FITN与之前分析的受试者进行比较:36名结肠镜检查阴性的粪便免疫化学检测假阳性(NFIT)、36名低风险病变患者(LR)和92名高风险病变或CRC患者(HR/CRC)。与HR/CRC相比,FITN显示四个基因的表达显著降低。此外,与NFIT和LR患者相比,FITN显示 和 的表达显著降低。多项逻辑模型证实,单独的 能够特异性地将FITN与NFIT、LR和HR/CRC区分开来,而 能够将FITN与假阳性FIT区分开来。最后,FITN与HR/CRC、LR或NFIT之间比较的ROC曲线分析报告AUC大于0.87,敏感性和特异性分别为83%和76%。CELTiC检测组被证实是识别CRC患者和区分粪便免疫化学检测假阳性受试者的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/3cf6204c8d61/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/3ece5b775585/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/ce4de05269d7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/97744e84da92/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/f57af796586b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/3cf6204c8d61/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/3ece5b775585/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/ce4de05269d7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/97744e84da92/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/f57af796586b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eba/7113625/3cf6204c8d61/gr4.jpg

相似文献

1
Colorectal cancer screening: Assessment of , , and as blood markers in faecal immunochemical test negative subjects.结直肠癌筛查:评估粪便免疫化学检测阴性受试者中[具体指标未给出]、[具体指标未给出]、[具体指标未给出]和[具体指标未给出]作为血液标志物的情况。
J Adv Res. 2020 Mar 3;24:99-107. doi: 10.1016/j.jare.2020.03.001. eCollection 2020 Jul.
2
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.LGALS4、CEACAM6、TSPAN8 和 COL1A2:粪便免疫化学检测结果阳性受试者队列中的结直肠癌血液标志物——验证研究。
Clin Colorectal Cancer. 2018 Jun;17(2):e217-e228. doi: 10.1016/j.clcc.2017.12.002. Epub 2017 Dec 12.
3
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.系统性大规模荟萃分析确定了一组由两个mRNA组成的panel作为结直肠癌检测的血液生物标志物。
Oncotarget. 2016 May 24;7(21):30295-306. doi: 10.18632/oncotarget.8108.
4
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.粪便免疫化学检测用于在初级保健中对有下腹部症状的患者进行分流,以确定是否需要转诊疑似结直肠癌患者:一项系统评价和成本效益分析。
Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330.
5
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.基于粪便细菌标志物的特征减少粪便免疫化学检测的假阳性结果。
Aliment Pharmacol Ther. 2019 Jun;49(11):1410-1420. doi: 10.1111/apt.15251. Epub 2019 Apr 25.
6
Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.低于阳性阈值的 FIT 值变化与结直肠高级别腺瘤近期风险:基于人群的癌症筛查项目研究结果。
Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10.
7
Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.采用粪便和尿液标志物对疑似结直肠癌的有症状患者进行风险分层。
Colorectal Dis. 2018 Dec;20(12):O335-O342. doi: 10.1111/codi.14431. Epub 2018 Oct 17.
8
Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.接受结直肠癌症筛查假阳性结果的心理社会后果:一项定性研究。
Scand J Prim Health Care. 2019 Jun;37(2):145-154. doi: 10.1080/02813432.2019.1608040. Epub 2019 May 11.
9
10
Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.参与者相关的粪便免疫化学检测在结直肠癌筛查中的假阳性和假阴性的危险因素:系统评价和荟萃分析。
Am J Gastroenterol. 2018 Dec;113(12):1778-1787. doi: 10.1038/s41395-018-0212-7. Epub 2018 Aug 29.

引用本文的文献

1
Dendrobium officinale Kimura et Migo regulates the proliferation and migration of colon adenocarcinoma via LGALS4.铁皮石斛通过LGALS4调节结肠腺癌的增殖和迁移。
Mol Divers. 2025 Sep 5. doi: 10.1007/s11030-025-11335-y.
2
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes.在两项既定筛查计划中,一种基于血液的结直肠癌附加筛查检测的诊断准确性。
Aliment Pharmacol Ther. 2025 Jun;61(12):1935-1943. doi: 10.1111/apt.70141. Epub 2025 Apr 10.
3
inhibits glycolysis and promotes apoptosis of colorectal cancer cells via β‑catenin signaling.

本文引用的文献

1
Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance.意大利全国 PASSI 监测项目中,宫颈癌、乳腺癌和结直肠癌筛查参与率、慢性病与健康相关行为之间的相关性。
Prev Med. 2019 Mar;120:60-70. doi: 10.1016/j.ypmed.2019.01.007. Epub 2019 Jan 16.
2
Liquid Biopsy for the Management of Patients with Colorectal Cancer.液体活检在结直肠癌患者管理中的应用。
Digestion. 2019;99(1):39-45. doi: 10.1159/000494411. Epub 2018 Dec 14.
3
Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
通过β-连环蛋白信号通路抑制结直肠癌细胞的糖酵解并促进其凋亡。
Oncol Lett. 2025 Jan 7;29(3):126. doi: 10.3892/ol.2025.14873. eCollection 2025 Mar.
4
Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker.评估 CEACAM6 作为血液转录标志物的潜在相关性。
F1000Res. 2024 Apr 4;11:1294. doi: 10.12688/f1000research.126721.2. eCollection 2022.
5
Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis.结直肠癌增殖中FBXW7基因突变的靶向变异患病率。首个系统评价与Meta分析。
Heliyon. 2024 May 22;10(11):e31471. doi: 10.1016/j.heliyon.2024.e31471. eCollection 2024 Jun 15.
6
Molecular Regulation and Oncogenic Functions of TSPAN8.四跨膜蛋白8(TSPAN8)的分子调控与致癌功能
Cells. 2024 Jan 19;13(2):193. doi: 10.3390/cells13020193.
7
The emerging roles of CEACAM6 in human cancer (Review).CEACAM6 在人类癌症中的新兴作用(综述)。
Int J Oncol. 2024 Mar;64(3). doi: 10.3892/ijo.2024.5615. Epub 2024 Jan 19.
8
DPHL v.2: An updated and comprehensive DIA pan-human assay library for quantifying more than 14,000 proteins.DPHL v.2:一个经过更新的综合性DIA全人类分析文库,用于定量分析超过14000种蛋白质。
Patterns (N Y). 2023 Jul 5;4(7):100792. doi: 10.1016/j.patter.2023.100792. eCollection 2023 Jul 14.
9
Identification of potential biomarkers in Barrett's esophagus derived esophageal adenocarcinoma.巴雷特食管衍生食管腺癌中潜在生物标志物的鉴定。
Sci Rep. 2023 Feb 9;13(1):2345. doi: 10.1038/s41598-022-17107-0.
10
A GNAS Gene Mutation's Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis.GNAS基因突变在结直肠癌生长中的独立表达:一项系统评价与Meta分析
Cancers (Basel). 2022 Nov 8;14(22):5480. doi: 10.3390/cancers14225480.
使用粪便免疫化学检测参与基于人群的结直肠癌筛查可降低5年内的死亡率。
Eur J Gastroenterol Hepatol. 2019 Feb;31(2):197-204. doi: 10.1097/MEG.0000000000001338.
4
Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study.在一项大型德国结直肠癌筛查研究中,与粪便免疫化学检测假阳性相关的因素。
Int J Cancer. 2019 May 15;144(10):2419-2427. doi: 10.1002/ijc.31972. Epub 2019 Jan 4.
5
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.液体活检在结直肠癌患者管理中的应用:当前应用和未来前景。
Cancer Treat Rev. 2018 Nov;70:1-8. doi: 10.1016/j.ctrv.2018.07.007. Epub 2018 Jul 18.
8
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.LGALS4、CEACAM6、TSPAN8 和 COL1A2:粪便免疫化学检测结果阳性受试者队列中的结直肠癌血液标志物——验证研究。
Clin Colorectal Cancer. 2018 Jun;17(2):e217-e228. doi: 10.1016/j.clcc.2017.12.002. Epub 2017 Dec 12.
9
Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.基于粪便免疫化学试验的结直肠癌筛查方案的长期效果。
Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3.
10
Colorectal cancer, screening and primary care: A mini literature review.结直肠癌、筛查和初级保健:小型文献综述。
World J Gastroenterol. 2017 Sep 7;23(33):6049-6058. doi: 10.3748/wjg.v23.i33.6049.